menu
    • menu
    [{"orgOrder":0,"company":"Peijia Medical","sponsor":"General Hospital of Shenyang Military Region | Shanghai Zhongshan Hospital | Guangdong Provincial People's Hospital | The Second Affiliated Hospital of Harbin Medical University | Air Force Military Medical University, China | West China Hospital | Beijin","pharmaFlowCategory":"DU","therapeuticArea":"Cardiology\/Vascular Diseases","country":"CHINA","productType":"Other Large Molecule","year":"2021","type":"Inapplicable","leadProduct":"Artificial Aortic Valve","moa":"Undisclosed","graph1":"Cardiology\/Vascular Diseases","graph2":"Undisclosed","graph3":"Peijia Medical","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Cardiovascular Diseases","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Peijia Medical \/ General Hospital of Shenyang Military Region | Shanghai Zhongshan Hospital | Guangdong Provincial People's Hospital | The Second Affiliated Hospital of Harbin Medical University | Air Force Military Medical University, China | West China Hospital | Beijin","highestDevelopmentStatusID":"1","companyTruncated":"Peijia Medical \/ General Hospital of Shenyang Military Region | Shanghai Zhongshan Hospital | Guangdong Provincial People's Hospital | The Second Affiliated Hospital of Harbin Medical University | Air Force Military Medical University, China | West China Hospital | Beijin"}]

    Find Clinical Drug Pipeline Developments & Deals by Peijia Medical

    Menu

    Peijia Medical

    EVENTS

    • Webinars & Exhibitions

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass
    Xls
    Filters Filter
    ×
    FILTER:
    filter
    Company Name
      filter

      Year

        filter

        DEALS // DEV.

          filter

          Country

            filter
            Sponsor
              filter

              Therapeutic Area

                filter

                Study Phase

                  filter

                  Deal Type

                    filter

                    Product Type

                      filter

                      Dosage Form

                        filter

                        Lead Product

                          filter

                          Target

                            Loading...
                            refresh Filters
                            refresh Reset Filter
                            refresh Reset Filter
                            price-trend All Developments

                            Therapeutic Area by Lead Product

                            Study Phase by Lead Product

                            Company by Lead Product

                            Top Deals by Deal Size (USD bn)

                            01

                            Peijia Medical

                            China arrow
                            Pharmaconex
                            Not Confirmed

                            Peijia Medical

                            China arrow
                            Pharmaconex
                            Not Confirmed
                            • fda
                            • EDQM
                            • WHO-GMP
                            Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

                            Lead Product(s) : Artificial Aortic Valve

                            Therapeutic Area : Cardiology/Vascular Diseases

                            Study Phase : Undisclosed

                            Sponsor : General Hospital of Shenyang Military Region | Shanghai Zhongshan Hospital | Guangdong Provincial People's Hospital | The Second Affiliated Hospital of Harbin Medical University | Air Force Military Medical University, China | West China Hospital | Beijin

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            DEALS_DEV arrow-down

                            Safety and Efficacy of TaurusOne® Transcatheter Aortic Valve Replacement System With Retrievable Delivery C...

                            Details : Undisclosed

                            Product Name : Undisclosed

                            Product Type : Other Large Molecule

                            Upfront Cash : Inapplicable

                            February 09, 2021

                            Lead Product(s) : Artificial Aortic Valve

                            Therapeutic Area : Cardiology/Vascular Diseases

                            Highest Development Status : Undisclosed

                            Sponsor : General Hospital of Shenyang Military Region | Shanghai Zhongshan Hospital | Guangdong Provincial People's Hospital | The Second Affiliated Hospital of Harbin Medical University | Air Force Military Medical University, China | West China Hospital | Beijin

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            blank

                            Stock Recap
                            #PipelineProspector

                            Data Compilation
                            #PharmaFlow

                            Virtual Booth